Piedmont Investment Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-12,456
Closed -$110K 112
2020
Q1
$110K Sell
12,456
-2
-0% -$29 ﹤0.01% 778
2019
Q4
$225K Sell
12,458
-2,146
-15% -$35.6K 0.01% 856
2019
Q3
$218K Sell
14,604
-1,203
-8% -$19.6K 0.01% 851
2019
Q2
$379K Sell
15,807
-1,118
-7% -$32.9K 0.02% 668
2019
Q1
$629K Sell
16,925
-5
-0% -$182 0.03% 434
2018
Q4
$478K Buy
16,930
+4,042
+31% +$128K 0.02% 477
2018
Q3
$508K Buy
+12,888
New +$564K 0.02% 509
2016
Q2
Sell
-40,596
Closed -$284K 642
2016
Q1
$284K Buy
40,596
+620
+2% +$3.12K 0.01% 256
2015
Q4
$214K Buy
39,976
+350
+0.9% +$2.24K ﹤0.01% 264
2015
Q3
$256K Buy
+39,626
New +$415K 0.01% 267

Other funds holding CC

Piedmont Investment Advisors's CC Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Chemours (CC) in Q2 2020, closing a stake of 12,456 shares — an estimated $110K sold.

Piedmont Investment Advisors first reported a position in CC in Q3 2015 and held it in 10 quarters. The position peaked at $629K in Q1 2019. 396 funds tracked by Wall St. Rank hold CC as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Chemours position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 12,456 Chemours shares in Q2 2020, an estimated $110K.
  • Piedmont Investment Advisors first reported a position in Chemours in Q3 2015 and held it in 10 quarters.
  • Piedmont Investment Advisors's Chemours position peaked at $629K in Q1 2019.
  • 396 funds tracked by Wall St. Rank held Chemours as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.